Previous terms continue: Approved consistent with the understanding that CDC will continue to work with SAMHSA on questions related to illicit drug use. The Agency will include the OMB control number and expiration date (as well as the burden statement) on all questionnaires and forms administered to participants in this collection
Inventory as of this Action
Requested
Previously Approved
02/28/2023
02/28/2023
02/28/2023
8,940
0
8,940
4,433
0
4,433
44,307
0
44,307
The purpose of BD-STEPS is to evaluate factors associated with the occurrence of birth defects and stillbirths and ultimately to work to prevent major birth defects and stillbirths associated with maternal risk factors. Subjects will be asked whether they were told by a healthcare provider that they had coronavirus or COVID-19. This change is being made to capture information on these infections in our study population of women who were pregnant during the SARS-CoV-2 pandemic.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Mother's Consent Script and Computer Assisted Telephone Interview
OMB0920-0010_BD-STEPS_NonSubstantive Change request .docx
AttX_PrivacyImpactAssessment.pdf
Mother's Consent Script and Computer Assisted Telephone Interview